Search results
Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolio
Associated Press via AOL· 6 months agoDrugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that...
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
Reuters via Yahoo News· 8 months ago(Reuters) -Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics...
Will Bristol Myers (BMY) Gain From New Drugs' Label Expansion?
Zacks via Yahoo Finance· 1 year agoBristol-Myers Squibb BMY has recently been enjoying a string of positive regulatory updates. The...
Bristol-Myers (BMY) Q3 Earnings Beat, Sales Decline Y/Y
Zacks via Yahoo Finance· 2 years agoBristol-Myers Squibb Company BMY reported decent results for the third quarter of 2022. The company...
Here’s Why Aristotle Atlantic Core Equity Strategy Sold Bristol-Myers Squibb Company (BMY)
Insider Monkey via Yahoo Finance· 3 months agoAristotle Atlantic Partners, LLC, an investment management company, released its “Core Equity...
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 1 year agoFor new and old investors, taking full advantage of the stock market and investing with confidence...
Top Analyst Reports for Bristol-Myers, Verizon & Canadian National Railway
Zacks via Yahoo Finance· 2 years agoToday's Research Daily features new research reports on 16 major stocks, including Berkshire...
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters via AOL· 9 months agoBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal...
Bristol Myers wins dismissal of a $6.4 billion lawsuit over cancer drug delay
Reuters via Yahoo News· 1 year agoNEW YORK (Reuters) -A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co...
Bristol Myers CEO sees mid-decade transition, late decade growth
Reuters via Yahoo Finance· 4 months ago(Reuters) -Bristol Myers Squibb's new chief executive said on Friday that the company was focused on...